Logo image of JEN.BR

JENSEN-GROUP NV (JEN.BR) Stock Fundamental Analysis

EBR:JEN - Euronext Brussels - BE0003858751 - Common Stock - Currency: EUR

55.2  +0.8 (+1.47%)

Fundamental Rating

6

Overall JEN gets a fundamental rating of 6 out of 10. We evaluated JEN against 103 industry peers in the Machinery industry. JEN scores excellent on profitability, but there are some minor concerns on its financial health. JEN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

JEN had positive earnings in the past year.
In the past year JEN had a positive cash flow from operations.
In the past 5 years JEN has always been profitable.
JEN had a positive operating cash flow in 4 of the past 5 years.
JEN.BR Yearly Net Income VS EBIT VS OCF VS FCFJEN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

With an excellent Return On Assets value of 7.97%, JEN belongs to the best of the industry, outperforming 87.38% of the companies in the same industry.
JEN has a Return On Equity of 14.57%. This is amongst the best in the industry. JEN outperforms 81.55% of its industry peers.
JEN has a better Return On Invested Capital (11.74%) than 86.41% of its industry peers.
The Average Return On Invested Capital over the past 3 years for JEN is in line with the industry average of 8.83%.
The last Return On Invested Capital (11.74%) for JEN is above the 3 year average (9.39%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.97%
ROE 14.57%
ROIC 11.74%
ROA(3y)6.55%
ROA(5y)5.36%
ROE(3y)12.05%
ROE(5y)10.23%
ROIC(3y)9.39%
ROIC(5y)8.21%
JEN.BR Yearly ROA, ROE, ROICJEN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of JEN (9.08%) is better than 84.47% of its industry peers.
JEN's Profit Margin has improved in the last couple of years.
The Operating Margin of JEN (11.20%) is better than 78.64% of its industry peers.
In the last couple of years the Operating Margin of JEN has grown nicely.
JEN has a worse Gross Margin (13.64%) than 91.26% of its industry peers.
In the last couple of years the Gross Margin of JEN has grown nicely.
Industry RankSector Rank
OM 11.2%
PM (TTM) 9.08%
GM 13.64%
OM growth 3Y8.87%
OM growth 5Y10.05%
PM growth 3Y17.42%
PM growth 5Y13.94%
GM growth 3Y8.28%
GM growth 5Y10.4%
JEN.BR Yearly Profit, Operating, Gross MarginsJEN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

6

2. Health

2.1 Basic Checks

JEN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, JEN has less shares outstanding
The number of shares outstanding for JEN has been increased compared to 5 years ago.
JEN has a worse debt/assets ratio than last year.
JEN.BR Yearly Shares OutstandingJEN.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
JEN.BR Yearly Total Debt VS Total AssetsJEN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

JEN has an Altman-Z score of 3.36. This indicates that JEN is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.36, JEN is doing good in the industry, outperforming 77.67% of the companies in the same industry.
JEN has a debt to FCF ratio of 3.68. This is a good value and a sign of high solvency as JEN would need 3.68 years to pay back of all of its debts.
JEN's Debt to FCF ratio of 3.68 is fine compared to the rest of the industry. JEN outperforms 66.99% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that JEN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.08, JEN belongs to the top of the industry, outperforming 83.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 3.68
Altman-Z 3.36
ROIC/WACC1.62
WACC7.23%
JEN.BR Yearly LT Debt VS Equity VS FCFJEN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

JEN has a Current Ratio of 1.73. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
JEN has a Current ratio (1.73) which is in line with its industry peers.
JEN has a Quick Ratio of 1.35. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
JEN has a Quick ratio of 1.35. This is in the better half of the industry: JEN outperforms 73.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.35
JEN.BR Yearly Current Assets VS Current LiabilitesJEN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

JEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.20%, which is quite impressive.
Measured over the past years, JEN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.40% on average per year.
Looking at the last year, JEN shows a quite strong growth in Revenue. The Revenue has grown by 13.26% in the last year.
The Revenue has been growing slightly by 6.41% on average over the past years.
EPS 1Y (TTM)26.2%
EPS 3Y32.2%
EPS 5Y16.4%
EPS Q2Q%37.94%
Revenue 1Y (TTM)13.26%
Revenue growth 3Y20.39%
Revenue growth 5Y6.41%
Sales Q2Q%16.76%

3.2 Future

The Earnings Per Share is expected to grow by 5.01% on average over the next years.
The Revenue is expected to grow by 3.68% on average over the next years.
EPS Next Y6.19%
EPS Next 2Y5.39%
EPS Next 3Y4.65%
EPS Next 5Y5.01%
Revenue Next Year12.93%
Revenue Next 2Y8.38%
Revenue Next 3Y6.45%
Revenue Next 5Y3.68%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JEN.BR Yearly Revenue VS EstimatesJEN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
JEN.BR Yearly EPS VS EstimatesJEN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.75, which indicates a correct valuation of JEN.
Based on the Price/Earnings ratio, JEN is valued a bit cheaper than the industry average as 72.82% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of JEN to the average of the S&P500 Index (27.45), we can say JEN is valued rather cheaply.
A Price/Forward Earnings ratio of 11.39 indicates a reasonable valuation of JEN.
65.05% of the companies in the same industry are more expensive than JEN, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of JEN to the average of the S&P500 Index (21.90), we can say JEN is valued slightly cheaper.
Industry RankSector Rank
PE 12.75
Fwd PE 11.39
JEN.BR Price Earnings VS Forward Price EarningsJEN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JEN is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as JEN.
Industry RankSector Rank
P/FCF 28.18
EV/EBITDA 8.84
JEN.BR Per share dataJEN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
JEN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.06
PEG (5Y)0.78
EPS Next 2Y5.39%
EPS Next 3Y4.65%

3

5. Dividend

5.1 Amount

JEN has a Yearly Dividend Yield of 1.33%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.93, JEN has a dividend in line with its industry peers.
With a Dividend Yield of 1.33, JEN pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 1.33%

5.2 History

The dividend of JEN decreases each year by -5.10%.
Dividend Growth(5Y)-5.1%
Div Incr Years2
Div Non Decr Years4
JEN.BR Yearly Dividends per shareJEN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

17.86% of the earnings are spent on dividend by JEN. This is a low number and sustainable payout ratio.
DP17.86%
EPS Next 2Y5.39%
EPS Next 3Y4.65%
JEN.BR Yearly Income VS Free CF VS DividendJEN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M
JEN.BR Dividend Payout.JEN.BR Dividend Payout, showing the Payout Ratio.JEN.BR Dividend Payout.PayoutRetained Earnings

JENSEN-GROUP NV

EBR:JEN (7/3/2025, 7:00:00 PM)

55.2

+0.8 (+1.47%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-19 2025-05-19
Earnings (Next)08-07 2025-08-07
Inst Owners9.15%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap531.58M
Analysts80
Price Target54.57 (-1.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.33%
Yearly Dividend0.77
Dividend Growth(5Y)-5.1%
DP17.86%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)122.92%
PT rev (3m)7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.47%
Valuation
Industry RankSector Rank
PE 12.75
Fwd PE 11.39
P/S 1.17
P/FCF 28.18
P/OCF 17.36
P/B 1.88
P/tB 2.31
EV/EBITDA 8.84
EPS(TTM)4.33
EY7.84%
EPS(NY)4.85
Fwd EY8.78%
FCF(TTM)1.96
FCFY3.55%
OCF(TTM)3.18
OCFY5.76%
SpS47.06
BVpS29.35
TBVpS23.91
PEG (NY)2.06
PEG (5Y)0.78
Profitability
Industry RankSector Rank
ROA 7.97%
ROE 14.57%
ROCE 15.62%
ROIC 11.74%
ROICexc 14.09%
ROICexgc 17.48%
OM 11.2%
PM (TTM) 9.08%
GM 13.64%
FCFM 4.16%
ROA(3y)6.55%
ROA(5y)5.36%
ROE(3y)12.05%
ROE(5y)10.23%
ROIC(3y)9.39%
ROIC(5y)8.21%
ROICexc(3y)11.13%
ROICexc(5y)10.46%
ROICexgc(3y)12.99%
ROICexgc(5y)12.14%
ROCE(3y)13.16%
ROCE(5y)11.32%
ROICexcg growth 3Y5.22%
ROICexcg growth 5Y2.88%
ROICexc growth 3Y5.28%
ROICexc growth 5Y0.03%
OM growth 3Y8.87%
OM growth 5Y10.05%
PM growth 3Y17.42%
PM growth 5Y13.94%
GM growth 3Y8.28%
GM growth 5Y10.4%
F-Score6
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 3.68
Debt/EBITDA 0.37
Cap/Depr 132.29%
Cap/Sales 2.59%
Interest Coverage 28.09
Cash Conversion 51.35%
Profit Quality 45.81%
Current Ratio 1.73
Quick Ratio 1.35
Altman-Z 3.36
F-Score6
WACC7.23%
ROIC/WACC1.62
Cap/Depr(3y)117.95%
Cap/Depr(5y)108.4%
Cap/Sales(3y)2.08%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.2%
EPS 3Y32.2%
EPS 5Y16.4%
EPS Q2Q%37.94%
EPS Next Y6.19%
EPS Next 2Y5.39%
EPS Next 3Y4.65%
EPS Next 5Y5.01%
Revenue 1Y (TTM)13.26%
Revenue growth 3Y20.39%
Revenue growth 5Y6.41%
Sales Q2Q%16.76%
Revenue Next Year12.93%
Revenue Next 2Y8.38%
Revenue Next 3Y6.45%
Revenue Next 5Y3.68%
EBIT growth 1Y24.53%
EBIT growth 3Y31.06%
EBIT growth 5Y17.1%
EBIT Next Year51.02%
EBIT Next 3Y17.26%
EBIT Next 5Y12.63%
FCF growth 1Y39.35%
FCF growth 3Y-6.22%
FCF growth 5Y1.6%
OCF growth 1Y41.62%
OCF growth 3Y-2.15%
OCF growth 5Y3.17%